November 10, 2015
1 min read
Save

NYU Langone appoints chair of radiation oncology

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Alec Kimmelman, MD, PhD, has been named chair of the department of radiation oncology at NYU Langone Medical Center.

His appointment is effective February 1, 2016.

Alec Kimmelman

Alec Kimmelman

“I am delighted to join the faculty of NYU Langone Medical Center, the NYU School of Medicine and the Perlmutter Cancer Center,” Kimmelman said in a press release. “The level of talent, the vibrant atmosphere and the commitment to cutting-edge research and outstanding clinical care were major attractions in my decision. I very much look forward to working with my colleagues in the department of radiation Oncology. Together, I am confident we will continue to make advances in treating deadly diseases and will lead the charge to develop novel diagnostic and therapeutic approaches.”  

Kimmelman previously served as associate professor in the departments of radiation oncology at Harvard Medical School and its major teaching affiliates, Dana-Farber Cancer Institute and Brigham and Women’s Hospital.

His laboratory has made seminal contributions to the biological underpinnings of pancreatic cancer. Kimmelman also is a practicing radiation oncologist specializing in the treatment of gastrointestinal cancers.

“We are delighted to welcome Dr. Kimmelman to the NYU Langone family to lead our exceptional team in the department of radiation oncology,” Robert I. Grossman, MD, dean and CEO of NYU Langone, said in a press release. “His work has greatly advanced the understanding of cancer biology and has set in motion new and promising approaches to treat cancer. We are confident he will enrich our already strong pancreatic cancer program, and help further our commitment to excellence in patient care, research and education at the Perlmutter Cancer Center.”